Co-Activation of STAT3 and YAP1 Signaling Pathways Limits EGFR Inhibitor Response in Lung Cancer

被引：0

作者：

Karachaliou, Niki ^{[1
]}

Chaib, Imane ^{[2
]}

Cardona, Andres ^{[3
]}

Lopez-Vivanco, Guillermo ^{[4
]}

Vergnenegre, Alain ^{[5
]}

Miguel Sanchez, Jose ^{[6
]}

Provencio, Mariano ^{[7
]}

De Marinis, Filippo ^{[8
]}

Passaro, Antonio ^{[8
]}

Carcereny, Enric ^{[9
]}

Reguart, Noemi ^{[10
]}

Garcia Campelo, Rosario ^{[11
]}

Santarpia, Mariacarmela ^{[12
]}

Viteri, Santiago ^{[1
]}

Molina Vila, Miguel Angel ^{[13
]}

Li, Xuefei ^{[14
]}

Zhou, Caicun ^{[15
]}

Moran, Teresa ^{[9
]}

Ramirez Serrano, Jose Luis ^{[2
,16
]}

Bivona, Trever ^{[17
]}

Ma, Patrick ^{[18
]}

Drozdowskyj, Ana ^{[19
]}

Cao, Peng ^{[20
]}

Rosell, Rafael ^{[21
]}

机构：

[1] Hosp Univ Quiron Dexeus, IOR, Barcelona, Spain

[2] Inst Invest Ciencies Germans Trias & Pujol, Lab Cellular & Mol Biol, Badalona, Spain

[3] Clin Country, Clin & Translat Oncol Grp, Bogota, Colombia

[4] Hosp Cruces, Baracaldo, Spain

[5] CHU Limoges, Limoges, France

[6] Hosp Univ La Princesa, Madrid, Spain

[7] Hosp Univ Puerta Hierro, Madrid, Spain

[8] European Inst Oncol, Div Thorac Oncol, Milan, Italy

[9] Catalan Inst Oncol Hospital Germans Trios & Pujol, Med Oncol, Badalona, Spain

[10] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain

[11] Hosp Univ A Coruna, La Coruna, Spain

[12] Univ Messina, Oncol & Pathol, Messina, Italy

[13] Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

[14] Shanghai Pulm Hosp, Med Oncol, Shanghai, Peoples R China

[15] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China

[16] Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona, Spain

[17] UCSF, Med, San Francisco, CA USA

[18] Wvu Canc Inst, Morgantown, WV USA

[19] Pivotal Sl, Stat, Madrid, Spain

[20] Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China

[21] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

lung cancer; STAT3; signaling; EGFR Inhibitor; YAP1;

D O I：

10.1016/j.jtho.2016.11.1714

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02b-047

引用

页码：S1216 / S1217

页数：2

共 50 条

[41] Antitumor activity of YAP1 inhibitor in K-Ras mutant lung cancer cells
Shimomura, Iwao
Yamamoto, Yusuke
Tada, Yuji
Tatsumi, Koichiro
Ochiya, Takahiro
CANCER SCIENCE, 2018, 109 : 1182 - 1182
[42] The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
Lu, Tingting
Li, Ziming
Yang, Ying
Ji, Wenxiang
Yu, Yongfeng
Niu, Xiaomin
Zeng, Qingyu
Xia, Weiliang
Lu, Shun
CANCER LETTERS, 2018, 423 : 36 - 46
[43] Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways
Chang, Yu-Ting
Peng, Hsuan-Yu
Hu, Chun-Mei
Tien, Sui-Chih
Chen, Yi-Ing
Jeng, Yung-Ming
Chang, Ming-Chu
MOLECULAR ONCOLOGY, 2023, 17 (08) : 1628 - 1647
[44] Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival
Hong, Soon Auck
Jang, Si-Hyong
Oh, Mee-Hye
Kim, Sung Joon
Kang, Jin-Hyung
Hong, Sook-Hee
PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (03) : 335 - 342
[45] Overexpression of YAP1 of EGFR-mutant lung adenocarcinoma before tyrosine kinase inhibitor is associated with poor survival
Hong, Soon Auck
Kang, Jin-Hyoung
Hong, Sook Hee
CANCER RESEARCH, 2018, 78 (13)
[46] PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies
Sen, Malabika
Kindsfather, Audrey
Danilova, Ludmila
Zhang, Feng
Colombo, Raffaele
LaPorte, Matthew G.
Kurland, Brenda F.
Huryn, Donna M.
Wipf, Peter
Herman, James G.
EPIGENETICS, 2020, 15 (6-7) : 604 - 617
[47] Triptolide, a Cancer Cell Proliferation Inhibitor, Causes Zebrafish Muscle Defects by Regulating Notch and STAT3 Signaling Pathways
Lee, Byongsun
Park, Yongjin
Lee, Younggwang
Kwon, Seyoung
Shim, Jaekyung
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
[48] A perylene derivative regulates HIF-1α and Stat3 signaling pathways
Chen, Han
Guan, Yongli
Yuan, Gu
Zhang, Qiang
Jing, Naijie
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (04) : 1496 - 1505
[49] Constitutive activation of STAT3 in Lung Cancer: Stable Retrovirus-mediated RNA Interference Against STAT3 Inhibited the in Vitro Growth of Lung Cancer
Takahashi, Takao
Adachi, Yosuke
Sugiyama, Yasuyuki
Gazdar, Adi F.
Minna, John D.
Shivapurkar, Narayan
Matta, Hittu
Nomura, Masaharu
Shigematsu, Hisayuki
Stastny, Victor
Echebiri, Chinyere
Girard, Luc
Sato, Mitsuo
CANCER RESEARCH, 2006, 66 (08)
[50] YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling
Gruber, Ralph
Panayiotou, Richard
Nye, Emma
Spencer-Dene, Bradley
Stamp, Gordon
Behrens, Axel
GASTROENTEROLOGY, 2016, 151 (03) : 526 - 539

← 1 2 3 4 5 →